– Xinhua Silk Road: Seraphim recibió la medalla de plata en la calificación de RSE de EcoVadis PEKÍN, 17 de agosto de 2022 /PRNewswire/ — Seraphim Energy Group Co., Ltd. (Seraphim), un fabricante líder mundial de productos solares, anunció recientemente que había recibido una medalla de…
Related Posts
MA’ADEN y GlassPoint firman un MOU para desarrollar la mayor planta de vapor de proceso solar del mundo
-MA’ADEN y GlassPoint firman un Memorando de Entendimiento para desarrollar la mayor planta de vapor de proceso solar del mundo…
Zoomlion Carries Forward Its International Market Development with Localization Strategy and Diversified Logistics
CHANGSHA, CHINA, June 24, 2022 /PRNewswire/ — Zoomlion Heavy Industry Science & Technology Co., Ltd. (“Zoomlion”; 1157.HK), a leading high-end…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.